TABLE 2

Comparison of 18F-DCFPyl Uptake in Normal Tissues in Control and MSG Studies

Average SULmeanAverage SULmax
TissueControl (n = 10)MSG (n = 10)Decrease (%) (n = 10)P*Control (n = 10)MSG (n = 10)Decrease (%) (n = 10)P*
Blood pool0.8 ± 0.10.7 ± 0.110.7 ± 12.50.0211.1 ± 0.20.9 ± 0.211.4 ± 19.10.081
Gluteus muscle0.2 ± 0.050.2 ± 0.047.9 ± 21.70.1000.3 ± 0.10.3 ± 0.12.7 ± 27.90.364
Liver4.5 ± 0.63.7 ± 0.615.7 ± 7.3<0.0015.8 ± 0.74.9 ± 0.714.6 ± 5.7<0.001
Spleen3.2 ± 0.92.1 ± 0.634.3 ± 11.1<0.0013.6 ± 1.12.5 ± 0.628.3 ± 13.40.001
Parotid glands9.1 ± 2.56.9 ± 2.926.1 ± 16.90.00315.3 ± 3.911.6 ± 3.823.9 ± 14.00.001
Submandibular glands8.9 ± 3.55.8 ± 2.934.7 ± 18.70.00115.1 ± 6.29.9 ± 4.835.0 ± 11.2<0.001
Lacrimal glands6.0 ± 1.33.4 ± 1.241.9 ± 18.9<0.0019.9 ± 3.45.1 ± 1.948.5 ± 12.5<0.001
Colon5.9 ± 1.23.3 ± 1.245.1 ± 13.8<0.0017.5 ± 1.44.2 ± 1.343.8 ± 12.9<0.001
Urinary bladder33.8 ± 9.927.9 ± 10.214.8 ± 30.20.05473.0 ± 29.363.5 ± 33.814.4 ± 32.50.124
Kidneys17.2 ± 4.612.1 ± 2.227.4 ± 12.10.00137.5 ± 9.627.4 ± 8.023.5 ± 26.10.012
  • * Adjusted for multiple testing using Benjamini–Hochberg method.

  • Boldface values indicate statistical significance at α = 0.05 level.